Concr CEO Irina Babina and CTO Matthew Griffiths unpack how Bayesian foundation models can excel at uncertainty management to ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...